Tonix outlines TNX-4800 Phase II with ~3,300 participants while scaling TONMYA to ~150 reps by September — See source for full details.
$TNXP
Price history, market instrument context, member research, and related headlines in one place.
TNXP key statistics
Tonix Pharmaceuticals Holding Corp. (TNXP) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $6.40, up $0.27 (4.40%) from the previous close of $6.13. It has traded between $6.01 and $6.72 in the latest session. Over the past year it has ranged from $6.01 to $20.69, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 1.4M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation